Funding

Dr. Fairweather has received funding for research in her Translational Cardiovascular Disease Research Laboratory at Mayo Clinic from a variety of organizations, including the National Institutes of Health (NIH), the American Heart Association (AHA) and Mayo Clinic.

Investigator & Role Grant Title Funding Source Duration
DeLisa Fairweather, Ph.D., principal investigator Preventing DCM using regenerative therapy in a mouse model of myocarditis/DCM (16GRNT3095000) Mayo Clinic Center for Regenerative Medicine grant 08/01/2016-07/31/2018
DeLisa Fairweather, Ph.D., principal investigator Sex differences in VitD/VDR during myocarditis/DCM (16GRNT3095000) AHA Grant-in-Aid 07/01/2016-06/30/2018
DeLisa Fairweather, Ph.D., principal investigator Sex differences in complement during myocarditis/DCM (R01 HL111938) National Heart, Lung, and Blood Institute of the NIH 06/01/2012-05/31/2018
DeLisa Fairweather, Ph.D., principal investigator Sex differences in sST2 in cardiomyopathy assessed using Mayo Clinic Biobank Mayo Clinic Cardiopulmonary Focused Research Team Award 04/30/2017-12/31/2017
DeLisa Fairweather, Ph.D., principal investigator Endocrine disruptors effect on inflammatory heart disease (R21 ES024414) National Institute of Environmental Health Sciences of the NIH 08/01/2014-07/31/2017